Expression of CD94 by ex vivo-differentiated NK cells correlates with the in vitro and in vivo acquisition of cytotoxic features

Meriem HasmimU1186-INSERM, Equipe labellisée Ligue contre le Cancer, Institut Gustave Roussy, 114 rue Edouard Vaillant, Villejuif, France

Nadine KhalifeU1186-INSERM, Equipe labellisée Ligue contre le Cancer, Institut Gustave Roussy, 114 rue Edouard Vaillant, Villejuif, France

Yanyan ZhangINSERM U1170, Gustave Roussy, F-94805, Villejuif, France;Paris-Sud University, F-91405, Orsay, France

Manale DoldurQatar Biomedical Research Institute, Doha, Hamad Bin Khalifa University, Qatar

Geralidne VisentinU1186-INSERM, Equipe labellisée Ligue contre le Cancer, Institut Gustave Roussy, 114 rue Edouard Vaillant, Villejuif, France

Stéphane TerryU1186-INSERM, Equipe labellisée Ligue contre le Cancer, Institut Gustave Roussy, 114 rue Edouard Vaillant, Villejuif, France

Julien Giron-MichelINSERM UMRS 1197, Hôpital Paul Brousse, Villejuif, Cedex, France;Université Paris-Saclay, France

Ruoping TangService d'Hématologie clinique et de thérapie cellulaire, AP-HP, Hôpital St Antoine, F-75012, Paris, France

François DelhommeauSorbonne Universités, UPMC Université Paris 06, UMR_S 938, CDR Saint-Antoine, F-75012, Paris, France;INSERM, UMR_S 938, CDR Saint-Antoine, F-75012, Paris, France;Sorbonne Universités, UPMC Université Paris 06, GRC n°7, Groupe de Recherche Clinique sur les Myéloproliférations Aiguës et Chroniques MYPAC, F-75012, Paris, France;Service d'hématologie biologique, AP-HP, Hôpital Saint-Antoine & Hôpital Armand-Trousseau, F-75012, Paris, France

Nicolas DulphyUMR-1160, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France; U 1160, Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France

Jean-Henri BourhisU1186-INSERM, Equipe labellisée Ligue contre le Cancer, Institut Gustave Roussy, 114 rue Edouard Vaillant, Villejuif, France;Department of Hematology and Bone Marrow Transplantation, Gustave Roussy Campus, Villejuif, France

Fawzia LouacheINSERM U1170, Gustave Roussy, F-94805, Villejuif, France;Paris-Sud University, F-91405, Orsay, France

Salem ChouaibU1186-INSERM, Equipe labellisée Ligue contre le Cancer, Institut Gustave Roussy, 114 rue Edouard Vaillant, Villejuif, FranceCorrespondence[email protected]

show all

Expression of CD94 by ex vivo-differentiated NK cells correlates with the in vitro and in vivo acquisition of cytotoxic features

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Expression of CD94 by ex vivo-differentiated NK cells correlates with the in vitro and in vivo acquisition of cytotoxic features

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date